These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32579977)

  • 41. The nitric oxide donor sodium nitroprusside attenuates recognition memory deficits and social withdrawal produced by the NMDA receptor antagonist ketamine and induces anxiolytic-like behaviour in rats.
    Trevlopoulou A; Touzlatzi N; Pitsikas N
    Psychopharmacology (Berl); 2016 Mar; 233(6):1045-54. PubMed ID: 26685991
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rethinking the paradigm: evaluation of ketamine as a neurosurgical anesthetic.
    Bowles ED; Gold ME
    AANA J; 2012 Dec; 80(6):445-52. PubMed ID: 23409639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia.
    Tassonyi E; Charpantier E; Muller D; Dumont L; Bertrand D
    Brain Res Bull; 2002 Jan; 57(2):133-50. PubMed ID: 11849819
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain--an in vivo microdialysis study.
    Tani Y; Saito K; Imoto M; Ohno T
    Eur J Pharmacol; 1998 Jun; 351(2):181-8. PubMed ID: 9687001
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.
    Coates KM; Flood P
    Br J Pharmacol; 2001 Oct; 134(4):871-9. PubMed ID: 11606328
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ABT-089, but not ABT-107, ameliorates nicotine withdrawal-induced cognitive deficits in C57BL6/J mice.
    Yildirim E; Connor DA; Gould TJ
    Behav Pharmacol; 2015 Apr; 26(3):241-8. PubMed ID: 25426579
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Subtype-selective nicotinic acetylcholine receptor agonists enhance the responsiveness to citalopram and reboxetine in the mouse forced swim test.
    Andreasen JT; Nielsen EØ; Christensen JK; Olsen GM; Peters D; Mirza NR; Redrobe JP
    J Psychopharmacol; 2011 Oct; 25(10):1347-56. PubMed ID: 20360159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
    Skoubis PD; Hradil V; Chin CL; Luo Y; Fox GB; McGaraughty S
    Neuroscience; 2006; 137(2):583-91. PubMed ID: 16289887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potentiation of analgesic efficacy but not side effects: co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats.
    Zhu CZ; Chin CL; Rustay NR; Zhong C; Mikusa J; Chandran P; Salyers A; Gomez E; Simler G; Lewis LG; Gauvin D; Baker S; Pai M; Tovcimak A; Brown J; Komater V; Fox GB; Decker MW; Jacobson PB; Gopalakrishnan M; Lee CH; Honore P
    Biochem Pharmacol; 2011 Oct; 82(8):967-76. PubMed ID: 21620806
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cognitive and subjective acute dose effects of intramuscular ketamine in healthy adults.
    Lofwall MR; Griffiths RR; Mintzer MZ
    Exp Clin Psychopharmacol; 2006 Nov; 14(4):439-49. PubMed ID: 17115871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of nicotinic inhibition in ketamine-induced behavior.
    Udesky JO; Spence NZ; Achiel R; Lee C; Flood P
    Anesth Analg; 2005 Aug; 101(2):407-411. PubMed ID: 16037153
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders.
    Roncarati R; Scali C; Comery TA; Grauer SM; Aschmi S; Bothmann H; Jow B; Kowal D; Gianfriddo M; Kelley C; Zanelli U; Ghiron C; Haydar S; Dunlop J; Terstappen GC
    J Pharmacol Exp Ther; 2009 May; 329(2):459-68. PubMed ID: 19223665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of ketamine on intraspinal acetylcholine release: involvement of spinal nicotinic receptors.
    Abelson KS; Goldkuhl RR; Nylund A; Höglund AU
    Eur J Pharmacol; 2006 Mar; 534(1-3):122-8. PubMed ID: 16612840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Subunit-dependent inhibition of human neuronal nicotinic acetylcholine receptors and other ligand-gated ion channels by dissociative anesthetics ketamine and dizocilpine.
    Yamakura T; Chavez-Noriega LE; Harris RA
    Anesthesiology; 2000 Apr; 92(4):1144-53. PubMed ID: 10754635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of α7 nicotinic acetylcholine receptor agonists on antipsychotic efficacy in a preclinical mouse model of psychosis.
    Kohlhaas KL; Bitner RS; Gopalakrishnan M; Rueter LE
    Psychopharmacology (Berl); 2012 Apr; 220(4):823-33. PubMed ID: 22038534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reversal of isolation-rearing-induced PPI deficits by an alpha7 nicotinic receptor agonist.
    Cilia J; Cluderay JE; Robbins MJ; Reavill C; Southam E; Kew JN; Jones DN
    Psychopharmacology (Berl); 2005 Oct; 182(2):214-9. PubMed ID: 16001118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of α4β2 nicotinic acetylcholine receptors in working memory impairment induced by repeated electroconvulsive seizures in rats.
    Hidaka N; Suemaru K; Kato Y; Araki H
    Epilepsy Res; 2013 Mar; 104(1-2):181-5. PubMed ID: 23219030
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ketamine's dose related multiple mechanisms of actions: Dissociative anesthetic to rapid antidepressant.
    Lavender E; Hirasawa-Fujita M; Domino EF
    Behav Brain Res; 2020 Jul; 390():112631. PubMed ID: 32437885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ketamine inhibits synaptic transmission and nicotinic acetylcholine receptor-mediated responses in rat intracardiac ganglia in situ.
    Harper AA; Rimmer K; Dyavanapalli J; McArthur JR; Adams DJ
    Neuropharmacology; 2020 Mar; 165():107932. PubMed ID: 31911104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.